HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VISEN PHARMA-B

19.600

-0.030-0.15%

Volume:3K

Turnover:60.69K

Market Cap:2.23B

PE:-8.03

High:19.610

Open:19.540

Low:19.530

Close:19.630

52wk High:47.100

52wk Low:18.500

Shares:114.00M

HK Float Shares:114.00M

Volume Ratio:0.19

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-2.440

ROE:-50.52%

ROA:-23.58%

PB:2.51

PE(LYR):-8.03

PS:14089.58

Loading ...

Overview Company News Filings

VISEN Pharmaceuticals Turns First Revenue in H1 2026 but Remains Loss-Making; Board Reshuffle Announced

Bulletin Express

VISEN Pharma Updates Board Composition and Committee Assignments

Bulletin Express

Visen Pharmaceuticals Files Board, Board Committee and Disclosure-Responsible Management List

Visen Pharma Independent Director Yao Zhengbin Resigns from Board

VISEN Pharma Sets 27 Aug 2026 Board Meeting to Approve H1 2026 Interim Results

Bulletin Express

VISEN Pharma Keeps Share Capital Unchanged in July 2026 and Meets Public-Float Requirement

Bulletin Express

VISEN PHARMA-B (02561) Surges Over 5% as Commercial Sales of Weizhengao Ramp Up, Marking a Shift to Product Monetization

VISEN Pharmaceuticals Grants 514,068 Share Awards to Senior Management and Employees

Bulletin Express

VISEN PHARMA-B Grants Over 514,000 Share-Based Awards

Visen Pharmaceuticals Grants 514,068 Share Awards Under Post-ipo Incentive Scheme

VISEN PHARMA-B Surges Over 7% Intraday Following Hospital's Adoption of Pioneering PTH Therapy

VISEN PHARMA-B Surges Nearly 30% Intraday as Market Focuses on Core Product Ramp-Up and Accelerated Commercialization of Weizhengao®

VISEN PHARMA-B Shares Surge Over 15% Following New Partnership on Healthcare Payment Models

VISEN PHARMA-B Executes Share Buyback Transaction on June 29

VISEN PHARMA-B Appoints Three New Non-Executive Directors

Visen Pharmaceuticals Files List of Directors with Hong Kong Stock Exchange

Visen Pharmaceuticals Appoints Khoury, Glass, Chang as Non-executive Directors

VISEN PHARMA-B Repurchases 4,000 Shares for Approximately HK$76,800

VISEN PHARMA-B Spends HK$95,000 on Share Buyback

Visen Pharmaceuticals files HKEX next-day disclosure return reporting share repurchase for treasury shares at HKD 19.8

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/02561/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02561","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02561\",,,,,undefined,":{"symbol":"02561","market":"HK","secType":"STK","nameCN":"VISEN PHARMA-B","latestPrice":19.6,"timestamp":1788248790832,"preClose":19.63,"halted":0,"volume":3100,"delay":0,"changeRate":-0.0015282730514517364,"floatShares":113999999,"shares":113999999,"eps":-2.44,"marketStatus":"Trading","change":-0.03,"latestTime":"09-01 15:59:47","open":19.54,"high":19.61,"low":19.53,"amount":60689,"amplitude":0.004075,"askPrice":19.97,"askSize":400,"bidPrice":19.6,"bidSize":1600,"shortable":3,"etf":0,"ttmEps":-2.424,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788250200000},"marketStatusCode":2,"adr":0,"listingDate":1742486400000,"exchange":"SEHK","adjPreClose":19.63,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"volumeRatio":0.192547,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02561\",,,,,undefined,":{"symbol":"02561","floatShares":113999999,"roa":"-23.58%","roe":"-50.52%","lyrEps":-2.44,"volumeRatio":0.192547,"shares":113999999,"dividePrice":0,"high":19.61,"amplitude":0.004075,"preClose":19.63,"low":19.53,"week52Low":18.5,"pbRate":"2.51","psRate":"14089.58","week52High":47.1,"institutionHeld":0,"latestPrice":19.6,"committee":0.6,"eps":-2.44,"divideRate":0,"volume":3100,"delay":0,"ttmEps":-2.424,"open":19.54,"prevYearClose":32.8,"prevWeekClose":19.98,"prevMonthClose":19.63,"prevQuarterClose":19.98,"fiveDayClose":19.98,"twentyDayClose":19.95,"sixtyDayClose":21},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02561\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"02561","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787794200000,"name":null,"time":"","dateTimestamp":1787760000000,"actualEps":null},{"date":"2026-03-12","symbol":"02561","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1773279000000,"name":null,"time":"","dateTimestamp":1773244800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02561\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02561\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1746460800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02561\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02561","date":"2026-08-31","current":-8.085809,"percent":0.965418,"low":-30.760225,"twenty":-26.637301,"median":-15.207337,"eighty":-8.93915,"high":-7.021664,"avg":-17.104093,"sd":7.585598,"marketCap":2140364195},"quantilePoints":[{"date":"2025-04-03","current":-21.475965,"twenty":-22.637245,"median":-22.569747,"eighty":-22.098421,"marketCap":5724824916},{"date":"2025-04-11","current":-18.134639,"twenty":-22.558476,"median":-18.349759,"eighty":-18.045823,"marketCap":4802017317},{"date":"2025-04-17","current":-25.787715,"twenty":-25.955056,"median":-22.513392,"eighty":-18.141011,"marketCap":4682394110},{"date":"2025-04-25","current":-29.965674,"twenty":-27.695216,"median":-22.653961,"eighty":-18.190408,"marketCap":5445704099},{"date":"2025-05-02","current":-28.244363,"twenty":-27.861811,"median":-26.066617,"eighty":-18.349759,"marketCap":5143797909},{"date":"2025-05-09","current":-27.581562,"twenty":-28.248468,"median":-27.028836,"eighty":-20.850724,"marketCap":5058352761},{"date":"2025-05-16","current":-27.481285,"twenty":-28.307048,"median":-27.470681,"eighty":-22.305907,"marketCap":5081138134},{"date":"2025-05-23","current":-29.180898,"twenty":-28.483617,"median":-27.481285,"eighty":-22.603559,"marketCap":5411526040},{"date":"2025-05-30","current":-27.585218,"twenty":-28.483617,"median":-27.495492,"eighty":-22.648389,"marketCap":5138101566},{"date":"2025-06-06","current":-26.147365,"twenty":-28.307048,"median":-27.481285,"eighty":-24.987287,"marketCap":5212154028},{"date":"2025-06-13","current":-28.707887,"twenty":-28.307048,"median":-27.486097,"eighty":-25.744296,"marketCap":5724824916},{"date":"2025-06-20","current":-27.87701,"twenty":-28.483617,"median":-27.500076,"eighty":-26.010837,"marketCap":5548238276},{"date":"2025-06-27","current":-26.600431,"twenty":-28.46744,"median":-27.491566,"eighty":-26.131215,"marketCap":5308991862},{"date":"2025-07-04","current":-25.999842,"twenty":-28.345085,"median":-27.470681,"eighty":-26.039907,"marketCap":5189368655},{"date":"2025-07-11","current":-25.483255,"twenty":-28.252573,"median":-27.442177,"eighty":-25.700877,"marketCap":5081138134},{"date":"2025-07-18","current":-27.275886,"twenty":-28.168194,"median":-27.211053,"eighty":-25.700877,"marketCap":5434311412},{"date":"2025-07-25","current":-27.917728,"twenty":-28.10544,"median":-27.177054,"eighty":-25.808828,"marketCap":5582416336},{"date":"2025-08-01","current":-26.858726,"twenty":-28.252573,"median":-27.236899,"eighty":-25.835301,"marketCap":5337473578},{"date":"2025-08-08","current":-26.45431,"twenty":-28.168194,"median":-27.174901,"eighty":-25.937332,"marketCap":5270256728},{"date":"2025-08-15","current":-27.513449,"twenty":-28.142473,"median":-27.236899,"eighty":-26.012565,"marketCap":5473046546},{"date":"2025-08-22","current":-26.703746,"twenty":-28.118557,"median":-27.177054,"eighty":-26.021282,"marketCap":5295320638},{"date":"2025-08-29","current":-26.119434,"twenty":-28.10544,"median":-27.144467,"eighty":-26.021282,"marketCap":5204179147},{"date":"2025-09-05","current":-23.791598,"twenty":-28.093765,"median":-27.114576,"eighty":-25.835301,"marketCap":4735670561},{"date":"2025-09-12","current":-23.381705,"twenty":-28.083375,"median":-27.05699,"eighty":-25.694259,"marketCap":4662460107},{"date":"2025-09-19","current":-23.051901,"twenty":-28.060478,"median":-27.021811,"eighty":-25.478949,"marketCap":4593433106},{"date":"2025-09-26","current":-21.933119,"twenty":-28.003961,"median":-26.881441,"eighty":-23.835003,"marketCap":4359159651},{"date":"2025-10-03","current":-19.179371,"twenty":-27.951558,"median":-26.814509,"eighty":-23.612343,"marketCap":4545323379},{"date":"2025-10-10","current":-18.42629,"twenty":-27.909584,"median":-26.722604,"eighty":-23.450061,"marketCap":4360487033},{"date":"2025-10-17","current":-18.280755,"twenty":-27.87397,"median":-26.671617,"eighty":-23.093007,"marketCap":4322679342},{"date":"2025-10-24","current":-17.856771,"twenty":-27.855424,"median":-26.557884,"eighty":-22.535934,"marketCap":4223959260},{"date":"2025-10-31","current":-16.854881,"twenty":-27.829876,"median":-26.452186,"eighty":-21.933119,"marketCap":3992912259},{"date":"2025-11-07","current":-16.17341,"twenty":-27.822718,"median":-26.363703,"eighty":-19.806882,"marketCap":3829078931},{"date":"2025-11-14","current":-14.606062,"twenty":-27.750423,"median":-26.249352,"eighty":-18.799844,"marketCap":3467805439},{"date":"2025-11-21","current":-13.329485,"twenty":-27.732081,"median":-26.119434,"eighty":-18.28655,"marketCap":3163243483},{"date":"2025-11-28","current":-13.563448,"twenty":-27.641863,"median":-26.021242,"eighty":-18.15057,"marketCap":3230457156},{"date":"2025-12-05","current":-15.697088,"twenty":-27.585218,"median":-25.856964,"eighty":-18.047863,"marketCap":3745061840},{"date":"2025-12-12","current":-16.915932,"twenty":-27.581562,"median":-25.811068,"eighty":-17.856771,"marketCap":4043322514},{"date":"2025-12-19","current":-15.561133,"twenty":-27.572592,"median":-25.748021,"eighty":-17.298197,"marketCap":3728258422},{"date":"2025-12-24","current":-15.871137,"twenty":-27.537106,"median":-25.592118,"eighty":-16.909424,"marketCap":3814375940},{"date":"2026-01-02","current":-14.633696,"twenty":-27.513319,"median":-25.499704,"eighty":-16.617104,"marketCap":3530818257},{"date":"2026-01-09","current":-14.6234,"twenty":-27.507904,"median":-25.36554,"eighty":-16.251482,"marketCap":3537119539},{"date":"2026-01-16","current":-14.627967,"twenty":-27.496935,"median":-23.827768,"eighty":-15.946573,"marketCap":3549722103},{"date":"2026-01-23","current":-16.340142,"twenty":-27.491697,"median":-23.637534,"eighty":-15.766708,"marketCap":3961405850},{"date":"2026-01-30","current":-14.661628,"twenty":-27.487059,"median":-23.520828,"eighty":-15.582389,"marketCap":3570726376},{"date":"2026-02-06","current":-14.624534,"twenty":-27.472802,"median":-23.381705,"eighty":-15.41764,"marketCap":3570726376},{"date":"2026-02-13","current":-14.275853,"twenty":-27.453945,"median":-23.154666,"eighty":-15.203628,"marketCap":3505613130},{"date":"2026-02-20","current":-14.390669,"twenty":-27.447813,"median":-22.932516,"eighty":-15.172676,"marketCap":3528717830},{"date":"2026-02-27","current":-13.887168,"twenty":-27.442691,"median":-22.626101,"eighty":-15.007296,"marketCap":3442600311},{"date":"2026-03-06","current":-13.692525,"twenty":-27.436603,"median":-22.183333,"eighty":-14.876498,"marketCap":3366984929},{"date":"2026-03-13","current":-13.213121,"twenty":-27.307751,"median":-21.922595,"eighty":-14.759688,"marketCap":3264063993},{"date":"2026-03-20","current":-11.103996,"twenty":-27.213507,"median":-20.641424,"eighty":-14.63255,"marketCap":2732655891},{"date":"2026-03-27","current":-11.448917,"twenty":-27.181226,"median":-19.179371,"eighty":-14.605,"marketCap":2810371700},{"date":"2026-04-02","current":-10.551094,"twenty":-27.175762,"median":-18.799844,"eighty":-14.511725,"marketCap":2602429399},{"date":"2026-04-10","current":-10.816815,"twenty":-27.169165,"median":-18.593258,"eighty":-14.452927,"marketCap":2688546918},{"date":"2026-04-17","current":-11.124817,"twenty":-27.145519,"median":-18.28655,"eighty":-14.356143,"marketCap":2766262727},{"date":"2026-04-24","current":-9.234794,"twenty":-27.140301,"median":-18.19085,"eighty":-14.276426,"marketCap":2684450661},{"date":"2026-04-30","current":-10.01242,"twenty":-27.130647,"median":-18.142604,"eighty":-14.218852,"marketCap":2911244218},{"date":"2026-05-08","current":-9.36492,"twenty":-27.114576,"median":-18.115304,"eighty":-13.966752,"marketCap":2732426221},{"date":"2026-05-15","current":-8.609823,"twenty":-27.082531,"median":-17.966643,"eighty":-13.803569,"marketCap":2518716908},{"date":"2026-05-22","current":-8.965761,"twenty":-27.063435,"median":-17.856771,"eighty":-13.603795,"marketCap":2616848736},{"date":"2026-05-29","current":-8.540077,"twenty":-27.053123,"median":-17.713814,"eighty":-13.46708,"marketCap":2501271250},{"date":"2026-06-05","current":-7.806526,"twenty":-27.033178,"median":-17.267927,"eighty":-13.258871,"marketCap":2289742644},{"date":"2026-06-12","current":-7.462138,"twenty":-27.023216,"median":-16.915932,"eighty":-12.86922,"marketCap":2187249401},{"date":"2026-06-18","current":-7.459122,"twenty":-27.00271,"median":-16.854881,"eighty":-11.79522,"marketCap":2191610816},{"date":"2026-06-26","current":-7.402496,"twenty":-26.938483,"median":-16.535359,"eighty":-11.467287,"marketCap":2164351975},{"date":"2026-07-03","current":-9.845227,"twenty":-26.885983,"median":-16.403537,"eighty":-11.112324,"marketCap":2880714316},{"date":"2026-07-10","current":-7.559024,"twenty":-26.848658,"median":-16.17341,"eighty":-10.890961,"marketCap":2209056474},{"date":"2026-07-17","current":-7.138134,"twenty":-26.818319,"median":-16.023664,"eighty":-10.603064,"marketCap":2093478988},{"date":"2026-07-24","current":-7.09936,"twenty":-26.773863,"median":-15.932493,"eighty":-9.912104,"marketCap":2082575452},{"date":"2026-07-31","current":-7.145258,"twenty":-26.733919,"median":-15.871137,"eighty":-9.576471,"marketCap":2100021110},{"date":"2026-08-07","current":-7.309141,"twenty":-26.699986,"median":-15.586393,"eighty":-9.407001,"marketCap":2152358085},{"date":"2026-08-14","current":-7.396048,"twenty":-26.682279,"median":-15.561133,"eighty":-9.341935,"marketCap":2180707280},{"date":"2026-08-21","current":-7.372359,"twenty":-26.66967,"median":-15.311996,"eighty":-9.225752,"marketCap":2178526572},{"date":"2026-08-28","current":-7.370688,"twenty":-26.649591,"median":-15.225883,"eighty":-8.995647,"marketCap":2178526572},{"date":"2026-08-31","current":-7.244653,"twenty":-26.637301,"median":-15.207337,"eighty":-8.93915,"marketCap":2140364195}],"updateTime":1788230078708},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02561\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1166290686","title":"VISEN Pharmaceuticals Turns First Revenue in H1 2026 but Remains Loss-Making; Board Reshuffle Announced","url":"https://stock-news.laohu8.com/highlight/detail?id=1166290686","media":"Bulletin Express","labels":["executive","dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166290686?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:23","pubTimestamp":1787840589,"startTime":"0","endTime":"0","summary":"VISEN Pharmaceuticals reported its maiden revenue of RMB34.54 million for the six months ended 30 June 2026, generated by the January launch of its once-weekly growth hormone therapy...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"VISEN Pharmaceuticals Turns First Revenue in H1 2026 but Remains Loss-Making; Board Reshuffle Announced","news_tag":"executive,dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199568407","title":"VISEN Pharma Updates Board Composition and Committee Assignments","url":"https://stock-news.laohu8.com/highlight/detail?id=1199568407","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199568407?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:22","pubTimestamp":1787840524,"startTime":"0","endTime":"0","summary":"VISEN Pharma (VISEN Pharmaceuticals, incorporated in the Cayman Islands) published an updated list of directors and their roles, effective 27 August 2026. The Board now comprises one executive...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662085197","title":"Visen Pharmaceuticals Files Board, Board Committee and Disclosure-Responsible Management List","url":"https://stock-news.laohu8.com/highlight/detail?id=2662085197","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662085197?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:18","pubTimestamp":1787840301,"startTime":"0","endTime":"0","summary":"Visen Pharmaceuticals files board, board committee and disclosure-responsible management listVisen Pharmaceuticals updated its board and committee roster dated Aug. 27, 2026, naming Fu Shan as board c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL3ssLM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662085986","title":"Visen Pharma Independent Director Yao Zhengbin Resigns from Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2662085986","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662085986?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:15","pubTimestamp":1787840117,"startTime":"0","endTime":"0","summary":"Visen Pharma independent director Yao Zhengbin resigns from boardVisen Pharmaceuticals independent non-executive director Dr. Yao Zhengbin (Bing) resigned effective Aug. 27, 2026, citing other busines","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL1h9Vcg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159299738","title":"VISEN Pharma Sets 27 Aug 2026 Board Meeting to Approve H1 2026 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1159299738","media":"Bulletin Express","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159299738?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:46","pubTimestamp":1786956363,"startTime":"0","endTime":"0","summary":"VISEN Pharmaceuticals has notified investors that its board will convene on 27 August 2026 to review and approve the interim financial results for the six months ended 30 June 2026. The meeting will...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130295885","title":"VISEN Pharma Keeps Share Capital Unchanged in July 2026 and Meets Public-Float Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=1130295885","media":"Bulletin Express","labels":["SGX","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130295885?lang=en_us&edition=fundamental","pubTime":"2026-08-03 17:09","pubTimestamp":1785748157,"startTime":"0","endTime":"0","summary":"VISEN Pharmaceuticals (VISEN Pharma, 02561.HK) released its Monthly Return for Equity Issuer for the period ended 31 July 2026, showing no movement in authorised, issued or treasury shares during the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139443372","title":"VISEN PHARMA-B (02561) Surges Over 5% as Commercial Sales of Weizhengao Ramp Up, Marking a Shift to Product Monetization","url":"https://stock-news.laohu8.com/highlight/detail?id=1139443372","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139443372?lang=en_us&edition=fundamental","pubTime":"2026-07-27 15:50","pubTimestamp":1785138619,"startTime":"0","endTime":"0","summary":"VISEN PHARMA-B (02561) shares climbed more than 5% in the late trading session, reaching HK$20.08, with a turnover of approximately HK$701,400. This comes after the company's core product,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","02561","VXUS","KCAI","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171473118","title":"VISEN Pharmaceuticals Grants 514,068 Share Awards to Senior Management and Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=1171473118","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171473118?lang=en_us&edition=fundamental","pubTime":"2026-07-20 21:02","pubTimestamp":1784552530,"startTime":"0","endTime":"0","summary":"VISEN Pharmaceuticals announced that its Board granted a total of 514,068 share awards on 20 July 2026 to 19 senior management members and employees under the company’s post-IPO share award scheme....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175850681","title":"VISEN PHARMA-B Grants Over 514,000 Share-Based Awards","url":"https://stock-news.laohu8.com/highlight/detail?id=1175850681","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175850681?lang=en_us&edition=fundamental","pubTime":"2026-07-20 20:43","pubTimestamp":1784551411,"startTime":"0","endTime":"0","summary":"VISEN PHARMA-B (HKEX: 02561) has issued an announcement regarding the grant of share-based incentives.On July 20, 2026, the company, under its established incentive plan, granted a total of 514,000...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652777213","title":"Visen Pharmaceuticals Grants 514,068 Share Awards Under Post-ipo Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2652777213","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652777213?lang=en_us&edition=fundamental","pubTime":"2026-07-20 20:30","pubTimestamp":1784550618,"startTime":"0","endTime":"0","summary":"Visen Pharmaceuticals grants 514,068 share awards under post-IPO incentive schemeVisen Pharmaceuticals granted 514,068 share awards to 19 senior managers and employees under its post-IPO scheme.Awards","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDL89y0g1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137146295","title":"VISEN PHARMA-B Surges Over 7% Intraday Following Hospital's Adoption of Pioneering PTH Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1137146295","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137146295?lang=en_us&edition=fundamental","pubTime":"2026-07-08 10:13","pubTimestamp":1783476831,"startTime":"0","endTime":"0","summary":"Shares of VISEN PHARMA-B (02561) experienced a notable intraday surge, climbing more than 7% at one point. As of the latest update, the stock was up 4.7%, trading at HK$20.96. The catalyst for this...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4588","BK1161","02561","BK4585","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118016983","title":"VISEN PHARMA-B Surges Nearly 30% Intraday as Market Focuses on Core Product Ramp-Up and Accelerated Commercialization of Weizhengao®","url":"https://stock-news.laohu8.com/highlight/detail?id=1118016983","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118016983?lang=en_us&edition=fundamental","pubTime":"2026-07-02 18:39","pubTimestamp":1782988785,"startTime":"0","endTime":"0","summary":"The Hong Kong-listed innovative drug sector, after a period of relative dormancy, has recently entered a phase of sustained upward momentum, with a clear trend of valuation recovery. On July 2nd, the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174931985","title":"VISEN PHARMA-B Shares Surge Over 15% Following New Partnership on Healthcare Payment Models","url":"https://stock-news.laohu8.com/highlight/detail?id=1174931985","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174931985?lang=en_us&edition=fundamental","pubTime":"2026-07-02 10:34","pubTimestamp":1782959668,"startTime":"0","endTime":"0","summary":"Shares of VISEN PHARMA-B (02561) experienced a significant rise of more than 15% during the morning trading session. At the time of writing, the stock was up 15.22%, trading at HK$23.02 with a...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","02561","BK4588","BK1161","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199483348","title":"VISEN PHARMA-B Executes Share Buyback Transaction on June 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1199483348","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199483348?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:00","pubTimestamp":1782734433,"startTime":"0","endTime":"0","summary":"VISEN PHARMA-B (ASX: 02561) has announced a share repurchase operation. On June 29, 2026, the company utilized HK$84,600 to buy back 4,300 of its own shares.This transaction represents the company's latest move in the market under its share repurchase program.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193537524","title":"VISEN PHARMA-B Appoints Three New Non-Executive Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=1193537524","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193537524?lang=en_us&edition=fundamental","pubTime":"2026-06-26 20:52","pubTimestamp":1782478335,"startTime":"0","endTime":"0","summary":"The board of VISEN PHARMA-B (02561) has announced the appointment of three new non-executive directors.Following approval by shareholders at the annual general meeting, the appointments of Mr. Roy...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646209357","title":"Visen Pharmaceuticals Files List of Directors with Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2646209357","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646209357?lang=en_us&edition=fundamental","pubTime":"2026-06-26 20:50","pubTimestamp":1782478252,"startTime":"0","endTime":"0","summary":"Visen Pharmaceuticals files list of directors with Hong Kong Stock ExchangeVisen Pharmaceuticals filed an updated list of directors with the Hong Kong Stock Exchange on June 26, 2026.Board includes ex","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL20d2Wy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646357145","title":"Visen Pharmaceuticals Appoints Khoury, Glass, Chang as Non-executive Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2646357145","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646357145?lang=en_us&edition=fundamental","pubTime":"2026-06-26 20:43","pubTimestamp":1782477831,"startTime":"0","endTime":"0","summary":"Visen Pharmaceuticals appoints Khoury, Glass, Chang as non-executive directorsVisen Pharmaceuticals appointed Roy Paul Khoury, Sherrie Lynn Glass, Michael J. Chang as non-executive directors, effectiv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL9wWwq8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178257432","title":"VISEN PHARMA-B Repurchases 4,000 Shares for Approximately HK$76,800","url":"https://stock-news.laohu8.com/highlight/detail?id=1178257432","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178257432?lang=en_us&edition=fundamental","pubTime":"2026-06-23 20:16","pubTimestamp":1782216983,"startTime":"0","endTime":"0","summary":"On June 23, 2026, VISEN PHARMA-B (02561) executed a share repurchase, buying back 4,000 of its own shares.The total expenditure for this transaction was approximately HK$76,800.The repurchase price ranged between HK$19.17 and HK$19.24 per share.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129311763","title":"VISEN PHARMA-B Spends HK$95,000 on Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1129311763","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129311763?lang=en_us&edition=fundamental","pubTime":"2026-06-22 18:10","pubTimestamp":1782123059,"startTime":"0","endTime":"0","summary":"On June 22, 2026, VISEN PHARMA-B (02561) allocated HK$95,000 to repurchase 4,800 of its own shares.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645025939","title":"Visen Pharmaceuticals files HKEX next-day disclosure return reporting share repurchase for treasury shares at HKD 19.8","url":"https://stock-news.laohu8.com/highlight/detail?id=2645025939","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645025939?lang=en_us&edition=fundamental","pubTime":"2026-06-22 18:05","pubTimestamp":1782122752,"startTime":"0","endTime":"0","summary":"Visen Pharmaceuticals repurchased 4,800 ordinary shares on June 22 for treasury, none for cancellation.Buyback executed on HKEX at HKD 19.8–19.81 per share; aggregate consideration HKD 95,041.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Visen Pharmaceuticals published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 22, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDLb8jNTL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":77,"code":"91000000","status":"200"}]}}